These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37820443)

  • 21. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
    Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
    J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes.
    Schmidt AF; Joshi R; Gordillo-Marañón M; Drenos F; Charoen P; Giambartolomei C; Bis JC; Gaunt TR; Hughes AD; Lawlor DA; Wong A; Price JF; Chaturvedi N; Wannamethee G; Franceschini N; Kivimaki M; Hingorani AD; Finan C
    Commun Med (Lond); 2023 Jan; 3(1):9. PubMed ID: 36670186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
    Berg G; Halperín H; Siseles N; Wikinski R
    Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.
    Belani SS; Goldberg AC; Coyne DW
    Am J Kidney Dis; 2004 Feb; 43(2):320-9. PubMed ID: 14750098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid metabolism in pregnancy. II. Altered lipid composition in intermediage, very low, low and high-density lipoprotein fractions.
    Warth MR; Arky RA; Knopp RH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):649-55. PubMed ID: 170295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherogenic lipoproteins in end-stage renal disease.
    Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.
    Magkos F; Mohammed BS; Mittendorfer B
    Int J Obes (Lond); 2008 Nov; 32(11):1655-64. PubMed ID: 18779822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol.
    Ito K; Yoshida H; Yanai H; Kurosawa H; Sato R; Manita D; Hirowatari Y; Tada N
    Int J Cardiol; 2013 Oct; 168(4):3853-8. PubMed ID: 23850319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
    Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
    Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C.
    Zambon A; Puato M; Faggin E; Grego F; Rattazzi M; Pauletto P
    Atherosclerosis; 2013 Sep; 230(1):106-9. PubMed ID: 23958261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.
    Sentí M; Nogués X; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
    Circulation; 1992 Jan; 85(1):30-6. PubMed ID: 1728461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance is not a major determinant of low-density lipoprotein particle size.
    Slyper AH; Zvereva S; Schectman G; Hoffmann RG; Mueller RA; Walker JA
    Metabolism; 1997 Nov; 46(11):1275-80. PubMed ID: 9361685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
    Balling M; Afzal S; Varbo A; Langsted A; Davey Smith G; Nordestgaard BG
    J Am Coll Cardiol; 2020 Dec; 76(23):2725-2735. PubMed ID: 33272366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.